Patents by Inventor Susanne Raab

Susanne Raab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical combination
    Patent number: 9132136
    Abstract: The present invention relates to a pharmaceutical combination for the treatment of schizophrenia and acute manic episodes associated with bipolar disorders, which comprises a compound which is active on a trace amine-associated receptor 1 (TAAR1 agonist) and an antipsychotic drug. This combination can reduce metabolic side effects which appear if using an antipsychotic drug alone.
    Type: Grant
    Filed: July 25, 2011
    Date of Patent: September 15, 2015
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Marius Hoener, Susanne Raab, Celine Risterucci, Sabine Sewing
  • PHARMACEUTICAL COMBINATION
    Publication number: 20130345201
    Abstract: The present invention relates to a pharmaceutical combination for the treatment of schizophrenia and acute manic episodes associated with bipolar disorders, which comprises a compound which is active on a trace amine-associated receptor 1 (TAAR1 agonist) and an antipsychotic drug. This combination can reduce metabolic side effects which appear if using an antipsychotic drug alone.
    Type: Application
    Filed: July 19, 2013
    Publication date: December 26, 2013
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Marius Hoener, Susanne Raab, Celine Risterucci, Sabine Sewing
  • Lipase inhibiting composition
    Patent number: 8343543
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ?37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: January 1, 2013
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Karsten Maeder, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Schroeder
  • PHARMACEUTICAL COMBINATION
    Publication number: 20120028964
    Abstract: The present invention relates to a pharmaceutical combination for the treatment of schizophrenia and acute manic episodes associated with bipolar disorders, which comprises a compound which is active on a trace amine-associated receptor 1 (TAAR1 agonist) and an antipsychotic drug. This combination can reduce metabolic side effects which appear if using an antipsychotic drug alone.
    Type: Application
    Filed: July 25, 2011
    Publication date: February 2, 2012
    Inventors: Marius Hoener, Susanne Raab, Celine Risterucci, Sabine Sewing
  • LIPASE INHIBITING COMPOSITION
    Publication number: 20110301231
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ?37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Application
    Filed: August 19, 2011
    Publication date: December 8, 2011
    Inventors: Karsten MAEDER, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Shroeder
  • Lipase inhibiting composition
    Patent number: 8039508
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ?37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: October 18, 2011
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Karsten Maeder, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Schroeder
  • Anti-obesity compositions
    Patent number: 7816342
    Abstract: The present invention relates to compositions and methods for treating obesity. More particularly, the invention relates to a composition comprising a lipase inhibitor such as orlistat, and glucomannan such as konjac as well as methods for utilizing such compositions and kits for carrying out this method.
    Type: Grant
    Filed: February 7, 2006
    Date of Patent: October 19, 2010
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Jacques Bailly, Rainer Eugen Martin, Susanne Raab
  • Naphthaline derivatives as H3 inverse agonists
    Patent number: 7608617
    Abstract: The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: October 27, 2009
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Silvia Gatti McArthur, Cornelia Hertel, Matthias Heinrich Nettekoven, Jean-Marc Plancher, Susanne Raab, Olivier Roche, Rosa Maria Rodriguez-Sarmiento, Franz Schuler
  • Quinoline derivatives as H3R inverse agonists
    Patent number: 7534891
    Abstract: The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof as well as to pharmaceutical compositions comprising these compounds and to methods for their preparation. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: May 19, 2009
    Assignee: Hoffman-La Roche Inc.
    Inventors: Silvia Gatti McArthur, Cornelia Hertel, Matthias Heinrich Nettekoven, Susanne Raab, Hans Richter, Olivier Roche, Rosa Maria Rodriguez-Sarmiento, Franz Schuler
  • Indole derivatives as H3 inverse agonists
    Patent number: 7361682
    Abstract: The present invention relates to compounds of formula I: wherein X, R1, R2, R3, R4 and R5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: April 22, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Silvia Gatti McArthur, Cornelia Hertel, Matthias Heinrich Nettekoven, Susanne Raab, Olivier Roche, Rosa Maria Rodriguez-Sarmiento, Franz Schuler, Jean-Marc Plancher
  • Naphthaline derivatives as H3 inverse agonists
    Publication number: 20070265254
    Abstract: The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: June 22, 2007
    Publication date: November 15, 2007
    Inventors: Silvia McArthur, Cornelia Hertel, Matthias Nettekoven, Jean-Marc Plancher, Susanne Raab, Olivier Roche, Rosa Rodriguez-Sarmiento, Franz Schuler
  • Naphthaline derivatives as H3 inverse agonists
    Patent number: 7259158
    Abstract: The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: August 21, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Silvia Gatti McArthur, Cornelia Hertel, Matthias Heinrich Nettekoven, Jean-Marc Plancher, Susanne Raab, Olivier Roche, Rosa Maria Rodriguez-Sarmiento, Franz Schuler
  • Anti-obesity compositions
    Publication number: 20060135471
    Abstract: The present invention relates to compositions and methods for treating obesity. More particularly, the invention relates to a composition comprising a lipase inhibitor such as orlistat, and glucomannan such as konjac as well as methods for utilizing such compositions and kits for carrying out this method.
    Type: Application
    Filed: February 7, 2006
    Publication date: June 22, 2006
    Inventors: Jacques Bailly, Rainer Martin, Susanne Raab
  • Quinoline derivatives as H3R inverse agonists
    Publication number: 20060084679
    Abstract: The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof as well as to pharmaceutical compositions comprising these compounds and to methods for their preparation. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: October 14, 2005
    Publication date: April 20, 2006
    Inventors: Silvia McArthur, Cornelia Hertel, Matthias Nettekoven, Susanne Raab, Hans Richter, Olivier Roche, Rosa Rodriguez-Sarmiento, Franz Schuler
  • Indole derivatives as H3 inverse agonists
    Publication number: 20050282864
    Abstract: The present invention relates to compounds of formula I: wherein X, R1, R2, R3, R4 and R5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Application
    Filed: June 20, 2005
    Publication date: December 22, 2005
    Inventors: Silvia McArthur, Cornelia Hertel, Matthias Nettekoven, Susanne Raab, Olivier Roche, Rosa Rodriguez-Sarmiento, Franz Schuler, Jean Marc Plancher
  • Lipase inhibiting composition
    Publication number: 20050101562
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ?37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Application
    Filed: December 23, 2004
    Publication date: May 12, 2005
    Inventors: Karsten Maeder, Rainer Martin, Susanne Raab, Lukas Scheibler, Thomas Schindler, Marco Schroeder
  • Anti-obesity compositions
    Publication number: 20040033983
    Abstract: The present invention relates to compositions and methods for treating obesity. More particularly, the invention relates to a composition comprising a lipase inhibitor such as orlistat, and glucomannan such as konjac as well as methods for utilizing such compositions and kits for carrying out this method.
    Type: Application
    Filed: April 23, 2003
    Publication date: February 19, 2004
    Inventors: Jacques Bailly, Rainer Eugen Martin, Susanne Raab
  • Lipase inhibiting composition
    Publication number: 20030027786
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ≧37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Application
    Filed: May 23, 2002
    Publication date: February 6, 2003
    Inventors: Karsten Maeder, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Schroeder